III. Transforming growth factor beta: Receptors, signals, and actions;III. TGF-β: Receptores, señales y acciones

Gaceta Medica de Mexico

Volumn 139, Issue 2, 2003, Pages 139-143

  López Casillas, Fernando ^a   Massagué, Joan ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CONFERENCE PAPER; DISEASE COURSE; GENE CONTROL; HUMAN; KIDNEY DISEASE; MITOGENESIS; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 0038031576     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Massagué J. The transforming growth factor-p family. Annu Rev Cell Biol 1990;6:597-641.
2. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetics tests of function in different organisms. Genes Dev 1994;8:133-146.
3. Massagué J, Blain SW, Lo RS. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
4. Biobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor P in human disease. N Engl J Med 2000; 342:1350-1358.
5. Massagué J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-791.
6. Massagué J, Chen Y-G. Controlling TGF-β signaling. Genes Dev2000;14:627-644.
7. Massagué J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 2000;1:169-178.
8. Wrana JL. Regulation of Smad activity. Cell 2000;100:189-192.
9. Massagué J, Attisano L, Wrana JL. The TGF-β family and its composite receptors. Trends Cell Biol 1994;4:172-178.
10. Wrana JL,Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-347.
11. Huse M, Muir TW, Xu L, Chen Y-G, Kuriyan J, Massagué J. The TGFβ receptor activation process: an inhibitor- to substrate binding switch. Mol Cells 2001;8:671-682.
12. Macias-Silva M, Abdollah S, Hoodiess PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 1996;87:1215-1224.
13. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998;95:779-91.
14. Xu L, Chen YG, Massague J. The nuclear import function of Smad2 is masked by SARA and unmasked by TGFbeta-dependent phosphorylation. Nat Cell Biol 2000-2:559-62.
15. Nako A, Afrakhte M, Moren A, et al. Identification of Smad7. a TGFβ-inducible antagonist of TGF-β signaling. Nature 1997;389:631-635.
16. Laiho M, Weis FMB, Massagué J. Concomitant loss of transforming growth factor-β receptor types I and II in cell mutants resistant toTGF-b. J. Biol Chem 1990;265:18518-18524.
17. Laiho M, Weis FMB, Boyd FT, Ignotz RA, Massagué J. Responsiveness to transforming growth factor-p restored by complementation between cells detective in TGF-β receptors I and II. J Biol Chem 1991;266:9108-9112.
18. Seoane J, Pouponnot C, Staller P, Schader M, Ellers M, Massague J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK in hibitor pl5iNK4b. Nat Cell Biol 2001;3:400-8.
19. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massague J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 2000;100:229-40.
20. Gripp KW, Wotton D, Edwards MC, et al. Mutations in TGIF cause holoprosencephaly and link NODAL signaling to human neural axis determination. Nat Genet 2000;25:205-8.
21. Lo RS, Wotton D, Massague J. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J 2001;20:128-36.
22. Hahn SA, Schutte M, Hoque ATMS, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-353.
23. Nurse P. A long twentieth century of the cell cycle and beyond. Cell 2000;100:71-78.
24. Murray A, Hunt T. The Cell Cycle, an introduction. New York: Oxford University Press, Inc., 1993.
25. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators od GIphase progression. Genes Dev 1999;13:1501-1512.
26. Warner BJ, Blain SW, Seoane J, Massague J. Myc down regulation by transforming growth factor beta required for activation of the pl5(Ink4b) G(I) arrest pathway. Mol Cell Biol 1999;19:5913-22.
27. Chen C-R, Kang Y, Siegel PM, Massague J. E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression. Cell 2002;110:19-32.